Neurology and Neurosurgery - Global Neurology Academy

Episodes 241-256 of 393

An Overview of MS Biomarkers
An Overview of MS Biomarkers
NeuroFrontiers
An Overview of MS Biomarkers
Discussing the Latest in MS Treatment and Disease-Modifying Therapies
Discussing the Latest in MS Treatment and Disease-Modifying Therapies
NeuroFrontiers
Discussing the Latest in MS Treatment and Disease-Modifying Therapies
- Charles Turck, PharmD, BCPS, BCCCP
- Jay Avasarala, MD, PhD
Highlights from the 2023 Psych Congress
Highlights from the 2023 Psych Congress
NeuroFrontiers
Highlights from the 2023 Psych Congress
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
- Craig Chepke, MD, FAPA
A New Hope for Patients with MS – The First FDA-Approved Biosimilar
A New Hope for Patients with MS – The First FDA-Approved Biosimilar
NeuroFrontiers
A New Hope for Patients with MS – The First FDA-Approved Biosimilar
Diagnosing Suspected MS: A Review of the Updated Guidelines
Diagnosing Suspected MS: A Review of the Updated Guidelines
NeuroFrontiers
Diagnosing Suspected MS: A Review of the Updated Guidelines
- Andrew Wilner, MD, FACP, FAAN
- Eoin Flanagan, MB, BCh
The Hidden Struggles of Tardive Dyskinesia: Improving Patient Care
The Hidden Struggles of Tardive Dyskinesia: Improving Patient Care
NeuroFrontiers
The Hidden Struggles of Tardive Dyskinesia: Improving Patient Care
Clarity for Schizophrenia: The Latest in Drug Treatment
Clarity for Schizophrenia: The Latest in Drug Treatment
NeuroFrontiers
Clarity for Schizophrenia: The Latest in Drug Treatment
Locked Up in My Own Mind: Challenges in the Criminal Justice System
Locked Up in My Own Mind: Challenges in the Criminal Justice System
NeuroFrontiers
Locked Up in My Own Mind: Challenges in the Criminal Justice System
New Drug Approved for PPD: Solving an Unmet Need
New Drug Approved for PPD: Solving an Unmet Need
NeuroFrontiers
New Drug Approved for PPD: Solving an Unmet Need
Studying the Safety of Discontinuing DMTs in MS Older Adults
Studying the Safety of Discontinuing DMTs in MS Older Adults
NeuroFrontiers
Studying the Safety of Discontinuing DMTs in MS Older Adults
- Andrew Wilner, MD, FACP, FAAN
- John R. Corboy, MD
Uncovering Disease Progression in Multiple Sclerosis
Uncovering Disease Progression in Multiple Sclerosis
NeuroFrontiers
Uncovering Disease Progression in Multiple Sclerosis
- Sergio Baranzini, PhD
Examining the Correlation Between HIV & Neurocognitive Disorders
Examining the Correlation Between HIV & Neurocognitive Disorders
NeuroFrontiers
Examining the Correlation Between HIV & Neurocognitive Disorders
- Jerome Lisk, MD, MBA, M.S., FAAN
- Santosh Kumar, PhD
Prescribing Controlled Substances Through Telehealth: Post-Pandemic Considerations
Prescribing Controlled Substances Through Telehealth: Post-Pandemic Considerations
NeuroFrontiers
Prescribing Controlled Substances Through Telehealth: Post-Pandemic Considerations
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
- Ashley Baker, MSN, PMHNP
NIH Study Identifies Cause for Long COVID Neurological Symptoms
NIH Study Identifies Cause for Long COVID Neurological Symptoms
NeuroFrontiers
NIH Study Identifies Cause for Long COVID Neurological Symptoms
- Charles Turck, PharmD, BCPS, BCCCP
- Avindra Nath, MD
The Cell Death Pathway: Leveraging Glioblastoma Treatments
The Cell Death Pathway: Leveraging Glioblastoma Treatments
NeuroFrontiers
The Cell Death Pathway: Leveraging Glioblastoma Treatments
- Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
- Dominique Higgins, MD, PhD
Special Report: Management Considerations and Unmet Needs in LGS and Dravet Syndrome
Special Report: Management Considerations and Unmet Needs in LGS and Dravet Syndrome
CME/CE
Special Report: Management Considerations and Unmet Needs in LGS and Dravet Syndrome
- Nilika Singhal, MD
- M. Scott Perry, MD
- Elizabeth Anne Thiele, MD, PhD

16/11